14/03/2019 22:45:45

Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Monday, March 18, 2019

MORRISVILLE, N.C., March 14, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), will release its fourth quarter and year end 2018 financial results and file its Form 10-K for the fiscal year ended December 31, 2018, after the market closes on Monday, March 18, 2019. The Company will host its earnings call at 5:30 p.m. ET that afternoon.

Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please dial +1 877 930 8058 within the United States or +1 253 336 7551 outside the United States, approximately 15 minutes prior to the scheduled start time. The conference ID for the call is 3768756.

A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 8:30 p.m. on March 18. In addition, an audio replay will be available for one week following the call and will be accessible by dialing +1 855 859 2056 within the United States or +1 404 537 3406 outside the United States. The replay ID is 3768756.

About Syneos Health

Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 23,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

   

Investor Relations Contact:

 

Press/Media Contact:

Ronnie Speight Danielle DeForge
Senior Vice President, Investor Relations Executive Director, External Communications
+1 919 745 2745 +1 781 425 2624

investor.relations@syneoshealth.com

 

danielle.deforge@syneoshealth.com

   

Syneos Health_rgb_tm.png

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Jun
 
Ingen grund til at flytte, de fleste har ikke råd, det er altid middelklassen det rammer og alligeve..
29
13 Jun
PNDORA
Hvad er det for noget eklatant ævl.Hvis man sammenholder de store fondes indtog på det danske aktiem..
24
15 Jun
PNDORA
Mit take på Pandora: Tidligere ledelse ønskede at væksten for vækstens skyld. Det har vist sig, a..
21
13 Jun
PNDORA
Jeg er meget imponeret over Jyske bank og i særdeleshed analytikkeren Janne Vincent Kjær. Kunne rest..
20
17 Jun
PNDORA
Jeg har forespurgt Pandora, hvorfor de overlader al kommunikation omkring virksomheden til negativt ..
18
15 Jun
PNDORA
Udover den samme analyse blev offentligjort for snart 3 uger siden er det da glimrende at man igen, ..
18
12 Jun
PNDORA
er i dag ude med en dødsdoms artikel omkring Pandora. Artiklen er skrevet af en velanset analytiker,..
17
12 Jun
NOVO-B
Novo Nordisk aktien er d.d. steget med 120 kr. siden d. 25. nov. 2016. Dvs. fra 226 til 346 kr. 💪 ..
17
18 Jun
AMBU-B
Jeg er rigtig tilfred med de udmeldinger JJG kommer med idag. Det giver ro over deres udmeldinger, o..
16
17 Jun
DANSKE
DB har jo IKKE brudt loven.  Nu er det sådan at det KUN er pressen der indfører love med tilbagevirk..
15

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Multiplying Good Recognizes Local Volunteers for Outstanding Public Service at 2019 Jefferson Awards in Washington, D.C.
2
Green Plains Prices Offering of $105 Million Aggregate Principal Amount of 4.00% Convertible Senior Notes due 2024
3
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Heron Therapeutics, Mammoth Energy, and ChinaCache and Encourages Investors to Contact the Firm
4
CLASS ACTION REMINDERS for FND, LTHM, PSMT, and AOS: Hagens Berman Reminds Investors of Class Actions on Behalf of Shareholders
5
CLASS ACTION REMINDERS for CLDR, TUSK and RMED: Hagens Berman Reminds Investors of Class Actions on Behalf of Shareholders

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 June 2019 12:55:21
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB3 - 2019-06-19 13:55:21 - 2019-06-19 12:55:21 - 1000 - Website: OKAY